Cimetidine-induced myelosuppression after bone marrow transplantation.

A strong temporal correlation was observed between cessation of cimetidine and a sustained increase in blood counts in two marrow transplant recipients. Both were receiving cimetidine from the day of transplantation for prophylaxis of stress ulceration and gastritis. The blood counts of both patients were not increasing satisfactorily 5-6 weeks after marrow transplantation without any obvious cause of marrow suppression. A similar observation has been made with the use of ranitidine after marrow transplantation suggesting that histamine H2-receptor antagonists should be used very cautiously, if at all, in the setting of bone marrow transplantation.

[1]  M. Tryba.  Sucralfate versus antacids or H2‐antagonists for stress ulcer prophylaxis: A meta‐analysis on efficacy and pneumonia rate , 1991, Critical care medicine.

[2]  E. Zanjani,et al.  Mechanism of Ranitidine Associated Anemia , 1989, The American journal of the medical sciences.

[3]  M. Mencoboni,et al.  Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide. , 1988, Anticancer research.

[4]  F. Appelbaum,et al.  Regimen-related toxicity in patients undergoing bone marrow transplantation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Shields,et al.  THE USE OF RANITIDINE IN BONE MARROW TRANSPLANTATION: A Review Of 223 Cases , 1988, Transplantation.

[6]  A. Nagler,et al.  Immune basis for cimetidine-induced pancytopenia. , 1987, The American journal of gastroenterology.

[7]  P. Gibson,et al.  Immune-mediated thrombocytopenia associated with ranitidine therapy. , 1986, The Medical journal of Australia.

[8]  L. Brenner.  Agranulocytosis and ranitidine. , 1986, Annals of internal medicine.

[9]  D. Doll,et al.  Ranitidine and agranulocytosis. , 1986, Annals of internal medicine.

[10]  R. Spychal,et al.  Has mortality related to alcohol decreased in Sweden? , 1985, British medical journal.

[11]  J. Delaney,et al.  Cimetidine-Associated Thrombocytopenia , 1983, Drug intelligence & clinical pharmacy.

[12]  R. Gamelli,et al.  HEMATOPOIETIC TOXICITY BY CIMETIDINE: REEXAMINATION USING THE ANTIMETABOLITE AZATHIOPRINE , 1983, Transplantation.

[13]  E. Beck,et al.  Reversible agranulocytosis in association with cimetidine and hepatic failure , 1982, Postgraduate medical journal.

[14]  Farber Bf,et al.  Rapid development of aplastic anemia after intravenous chloramphenicol and cimetidine therapy. , 1981 .

[15]  R. Crapper.  FATAL AGRANULOCYTOSIS ATTRIBUTABLE TO CIMETIDINE , 1981, The Medical journal of Australia.

[16]  J. Fitchen,et al.  Cimetidine and Granulopoiesis: Bone Marrow Culture Studies in Normal Man and Patients with Cimetidine‐associated Neutropenia , 1980, British journal of haematology.

[17]  Borda Ec,et al.  Current patterns of breast feeding in a New South Wales maternity hospital. , 1978 .